Anti-VEGF antibodies and their uses
US9079953B2 · kind B2 · utility
17Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2010 |
| Grant date | Jul 14, 2015 |
| Priority date | — |
| Expiry date | Jul 1, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibodies directed to vascular endothelial growth factor (“VEGF”) and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of VEGF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.